3.4. In Vitro Treatment with CCR5 Antagonist Maraviroc Increased the Migration of Irradiated CD8+ T Cells towards the Irradiated Tumour Compartment and Enhanced Production of IFN-γ by CD4+ T Helper Cells. Here, CD8A is linked to neoplasm.